(R)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-methylheptanoic acid, 95.0%, 250mg

Tributilamina, mínimo 99 %, para síntesis, 500 ml, envase de vidrio

1,2,3,4-Tetrahydroisoquinolin-5-ol hydrochloride, 95.0%, 1g

Ethyl 6-iodonicotinate, 98%, 5g

2-AMINOMETHYL-1-METHYLAZETIDINE, 95.0%, 250mg

TERT-BUTYL 3-AMINO-3-ETHYLAZETIDINE-1-CARBOXYLATE, 95.0%, 250mg

(S)-4,5-dichloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide, 97%, 250mg

N-[4-(methylsulfonyl)-2-nitrophenyl]-1,3-benzodioxol-5-amine, 1g

1,3-Dioxoisoindolin-2-yl acetate, 98%, 5g

6-BROMO-3-FLUOROPYRIDIN-2-AMINE, 95.0%, 250mg

1-Chloro-2,5-diethoxybenzene>98.0%(GC)500g

N-(tert-Butoxycarbonyl)-6-aminohexanoic Acid>95.0%(GC)(T)5g

Talco, Ph.Eur., USP, polvo, aproximadamente 44 µm, 250 g, envase de plástico.